← Back to GILD

GILEAD SCIENCES INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSSep 2026Filed 30/10/2026Jun 2026Filed 06/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 30/10/2026Jun 2025Filed 06/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 07/11/2025Jun 2024Filed 07/08/2025
$8,300$7,803$6,960$7,769$7,082$6,667$7,545$6,954
$2,429−$10,496$2,021$3,052$1,960$1,315$1,253$1,614
$1.94−$8.45$1.61$2.43$1.56$1.04$1.00$1.29
1,2511,2431,2541,2541,2551,2591,2541,251

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.